Quicker, Better, Faster Optimising Turn Around Time of Laboratory Results

Similar documents
Specimen Management PHRU LAB

Prior to site activation the following events were lined up

MTN 015 SPECIMEN REVIEW. Gabriel Banda Core Lab Supervisor UNC Project, Lilongwe

MTN-038 Laboratory Training. May Beamer, Michele Austin MTN Laboratory Center Magee-Womens Research Institute Pittsburgh, PA

The laboratory preparation for a new study a pragmatic approach. Compiled by Ken Clarke and Lindiwe Nhlangulela October 2011

QA Processes That Work: Minimizing Errors During On-site Rapid HIV Testing

MTN 005 Laboratory Training. Lorna Rabe MTN Network Laboratory Magee-Womens Research Institute Pittsburgh, PA

SCREENING AND ENROLLMENT CONSIDERATIONS MTN-038 STUDY-SPECIFIC TRAINING

GSK , 2.0, 18, 2014, DAIDS

HPTN 035. Laboratory Overview

VOICE Screening Part 1 Visit. Operational Walkthrough Johannesburg, South Africa November 2008

Section 12. Laboratory Considerations

VOICE (MTN-003) IT S ALL ABOUT THE ENDPOINTS. Edward Livant MT (ASCP), MPH University of Pittsburgh Medical Center MTN Network Laboratory

WOMEN'S INTERAGENCY HIV STUDY

Section 9. Laboratory Considerations

The Feasibility of HIV Prevention Cohort Studies among Men who have Sex with Men (MSM) in sub-saharan Africa

Section 9 Laboratory Consideration

ENHANCING LAB PERFORMANCE

Section 8. Clinical Considerations

Section 5. Study Procedures

SEXUAL HEALTH LAB PRODUCTS

Section 6. Participant Follow-up

Overview of Enrollment/Initiate Period 1 Visit Procedures

Section 13. Laboratory Considerations

MTN-038 SSP Manual Version November 2018 Section 10 Page 10-1 of 10-30

Section 9. Laboratory Considerations

Overview of Wet Preps and Gram stains. Lorna Rabe Central Lab Magee-Womens Research Institute Pittsburgh, Pa

Medicaid Family Planning Waiver Services CPT Codes and ICD-10 Diagnosis Codes

HIV Basics: Clinical Tests and Guidelines

Pathology Specimen Handling Requirements

TRICHOMONAS VAGINALIS

Section 5. Study Procedures

Sexually Transmitted Infections in HSV-2 Seropositive women in Sub- Saharan Africa HPTN 039

MTN 009 Laboratory Logistics

9.1 Overview and General Guidance This section contains information on the laboratory procedures performed in MTN-035.

H. PYLORI AB, IGG HPYL

CERTIFICATE OF ACCREDITATION

How best to structure a laboratory network with new technologies

USER GUIDE FOR SPECIMEN COLLECTION

MTN-020. Jared Baeten, MD PhD Thesla Palanee, PhD On behalf of the ASPIRE team MTN Annual Meeting, Bethesda 21 February 2012

Refocussing on STI management to impact HIV prevention

CERTIFICATE OF ACCREDITATION

MTN-020 and IPM 027 and the MTN-020 DSMB. Jared Baeten, MD PhD Thesla Palanee, PhD ASPIRE Protocol Team Meeting 22 February 2012

Sexually Transmitted Infections in the Adolescent Population. Abraham Lichtmacher MD FACOG Chief of Women s Services Lovelace Health System

N ational STI M icrobiological Surveillance Programme David A. Lewis FRCP(UK) PhD

Anti-Infective Clinical Trials

TEST LIST SAMPLE REQUIREMENT. 1 ml serum None

Integrating HIV Screening Into

Processing of female genital specimens at Labtests and Northland Pathology Laboratory

Unigold Recombigen HIV 1/2 Training for HIV Testing Sites. Updated: February 2018 Cicely Richard Office of HIV/AIDS

IP Lab Webinar 8/23/2012

CERTIFICATE OF ACCREDITATION

M E D I C A L L A B O R A T O R Y

M E D I C A L L A B O R A T O R Y

M.D.IPA, M.D.IPA Preferred, Optimum Choice and Optimum Choice Preferred STAT Laboratory List Revised Jan. 5, 2017

Follow-up Visit Procedures MTN-009

Testing Kits. Pregnancy Test Kits. Hepatitis Test Kits. HIV - 1 & 2 Test Kits

ONLINE SUPPLEMENTARY MATERIALS: FILE 1

Section 6. Participant Follow-up

TEST REQUEST INFORMATION- VIROLOGY

HEALTH ASSESSMENT FOR NEW ZEALAND VISA APPLICANTS

Management of NGU (Non-gonococcal urethritis)

Transfusion Medicine (Comprehensive, Limited) J, J1

SUMMARY OF CHANGES INCLUDED IN THE FULL PROTOCOL AMENDMENT OF: MTN-004 DAIDS Document ID 10492

Sexual health screening

Balancing investment in point of care diagnostics versus laboratory testing in low resource settings. June 28, 2011

Rapid Point-of-Care Tests for STIs: needs, progress, challenges

CDC Laboratory Update

Robert G. Gish MD UC San Diego

Specimen Submission Guide

M E D I C A L L A B O R A T O R Y

CERTIFICATE OF ACCREDITATION

Med Chem 535P ~ Diagnostic Medicinal Chemistry. General Comments

New Molecular Diagnostic Assays for Solana Performance Assessment, Workflow Analysis, and Clinical Utility

The new Cervical Screening Test for Australian women: Louise Farrell

Cost drivers in Microbiology/Serology laboratory testing: some perspectives

Medical Laboratory Accreditation Programme

Evaluation of VACUETTE Urine CCM Tubes for Urine Strip Testing

Lymphogranuloma Venereum (LGV) Surveillance Project

Specimen Submission Guide

An Update on FACTS 001. Prof Helen Rees FACTS Protocol Chair

Clinical Management Guidelines 2012

Guidelines for Specimen Submission to Pathology Laboratory

Specimen Collection & Handling Instructions HUMAN PAPILLOMAVIRUS (HPV) COLLECTION IN SUREPATH

MTN-038 Clinical Considerations. Site Specific Training 11 Sept 2018

Standard Operating Procedure

Safety Profile of Viread and Truvada. Ian McGowan, MD PhD FRCP Cape Town MTN Regional Meeting September, 2008

Corporate Medical Policy

HIV and PEP. LTC Rose Ressner WRNMMC ID staff Oct 2014 UNCLASSIFIED

Pathology the missing link in global health care delivery Quentin Eichbaum

Physician Office Laboratory Tests

Health Screening for Nanyang Technological University (NTU)

Make the BD FocalPoint GS Imaging System your guide in cervical cytology screening. Computer-guided screening

What s New. Vaginal Discharge Protocol. History

Siemens Healthcare Diagnostics

Nothing to disclose.

AccuSet HIV-1/2 Performance Panel

Remind me, what s an STI? And why are they relevant to me?

Reliable, cost-effective CT/GC testing For labs with low to medium throughput needs. The BD ProbeTec ET System

Transcription:

Quicker, Better, Faster Optimising Turn Around Time of Laboratory Results Pranitha Ramchuran Regulatory Compliance Manager MTN 003 Regional Meeting Cape Town, South Africa October 2011

Outline Organogram Turn around time (TATs) for lab results On-Site Testing Outsourced Testing Rationale for Selection of Outsourced Laboratories CLS and BARC TATs Clinic Flow of Results Challenges and Resolutions

LABORATORY ORGANOGRAM PI/ Research Clinician: Sinead Delany-Moretlwe Investigator of Record Thesla Palanee WRHI Laboratory Manager: Mandla Mlotshwa (Back Up) Research Clinician Modulakgotla Sebe; Nina Von Knorring; Kgomotso Morakane Ramasodi; Ogheneruemu Vincent Okwuolise Research Nurses: Angel Nyathi (ATN) Nkgolo Gegana (NMG) Aloysia Makau (AM) Xolelwa Matikinca (XJM) Christine Mapule Maruma (CMM) Regulatory Compliance Manager: Pranitha Ramchuran Clinical Quality Improvement Mentor (CQIM): Lebogang Modise (CLM) Busi Mnguni (BM) Medical Technologist: Lindelwa Nkangane (LN) Medical Technologist: Nomfundo Maduna (Back Up) Colour Key: HIV, Vaginal ph; TV; BV Preg, Urine Dipstick, Wet Mount, Internal QC

On-Site Laboratory Testing Laboratory Specimens and Testing Urine Blood Genital SDA: GC/CT BARC (Separation 5ml) Pregnancy Testing: Quidel QuickVue HIV Serology: Abbot Determine OraSure OraQuick Unigold Recombigen Vaginal ph Machery-Nagel Vaginal Gram Stain Vaginal Swab Endocervical Swab MTN Network Lab Urinalysis: Bayer Uristix 4/ Multistix 9 Rapid TV; BV OSOM Trichomonas BV Blue KOH Wet Mount

Rationale for Selection of Outsourced Laboratories Service providers identified CLS, BARC (Jhb/Dbn), MRC Central Laboratory (Dbn) Technical protocols developed Past experiences Quickest TATs Financial Penalty Clauses implemented Bioanalytical Research Corporation (BARC): GC/CT Pap Smear: Quicker TAT than MRC Central Laboratory (Dbn) (3-4 days vs 5 days) Quicker TAT than CLS 3 days vs 24 hours Change from conventional smear to liquid based cytology More sensitive Reduces call back of ppts due to inadequate pap smears Reduce time between Scr 1 and Scr 2

MTN 003 Outsourced Laboratory Testing Laboratory Specimens and Testing Serology: HBsAg HBsAb HIV Western Blot Haematology: FBC Flow Cytometry: CD4+ T-cells PCR: Viral Load Plasma Archive Urine: SDA: GC/CT Chemistry: AST; ALT; Phosphorous; Creatinine Storage: Vaginal Gram Stain Vaginal Swab Endocervical Swab MTN Network Lab Pap Smear: BD Surepath

Discipline Test Turn around time (TAT) Lab Performing the Assay Back-up Lab Serology HBsAg HBsAb 2 working days CLS Jhb National Health Laboratory Services (NHLS) Syphilis 3 working days CLS Jhb NHLS Jhb HIV Western Blot 5 working days National Institute of Communicable Diseases (NICD) NHLS Jhb Haematology Chemistry Full Blood Count AST; ALT; Phosphorous; Creatinine 48 hours CLS Jhb NHLS Jhb 24 hours CLS Jhb NHLS Jhb PCR Viral Load 5 working days NHLS Jhb NHLS Jhb Flow Cytometry CD4+ T-cells 24 hoursweekdays NHLS Jhb NHLS Jhb 72 hoursweekends and public holidays

Discipline Test Turn Around Time (TAT) Lab Performing Assay Back-up Lab Molecular Biology SDA GC/CT 3-4 days BARC KZN Lancet Jhb Cytology Pap Smear (BD Surepath Liquid based cytology 24 hours Lancet Cytology Jhb BARC Inhouse Multiple back-ups

Outsourced Testing Visit-specific sample requisition forms Volumes If indicated samples Urgent Samples requiring testing Use of URGENT stickers Phone calls and emails to CLS/BARC Accrual Phase: Urgent Screening Samples Follow-up Phase: AE Follow-up Seroconvertor Samples Communication with CLS and BARC Equipment and Consumable related delays

Flow of Laboratory Results QC of Requisition form Shipping of samples Clinical Review and Management Generation of DCFs Receipt and QC of Results

Challenges: Staff Capacity One Clinician Transcription delays Additional clinicians employed Med Tech employed QC systems improved High freq of DCFs Requisition forms Lab Result Reports Shipping Logs DCF Resolution within 24 hours

Acknowledgements Lab and Clinical Team at